-
Nuchal translucency as a marker of congenital heart disease.
Perdu M, Hyett JA, Sharland G, Snijders RS, Nicolaides KH.
Contracept Fertil Sex 1999;27:I-V. -
Investigation of the cause of miscarriage and its influence on women's psychological distress.
Nikcevic AV, Tunkel SA, Kuczmierczyk AR, Nicolaides KH.
BJOG 1999;106:808-13. -
Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 weeks.
Matias A, Huggon I, Areias JC, Montenegro N, Nicolaides KH.
Ultrasound Obstet Gynecol 1999;14:307-10. -
Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study.
Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH.
BMJ 1999;318:81-5. -
First-trimester determination of fetal gender by ultrasound.
Efrat Z, Akinfenwa Y, Nicolaides KH.
Ultrasound Obstet Gynecol 1999;13:305-7. -
First trimester umbilical venous Doppler sonography in chromosomally normal and abnormal fetuses.
Brown RN, Di Luzio L, Gomes C, Nicolaides KH.
J Ultrasound Med 1999;18:543-6. -
Collagen type VI gene expression in the skin of trisomy 21 fetuses.
von Kaisenberg CS, Brand-Saberi B, Christ B, Vallian S, Farzaneh F, Nicolaides KH.
Obstet Gynecol 1998;91:319-23. -
Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation.
Souka AP, Snijders RJ, Novakov A, Soares W, Nicolaides KH.
Ultrasound Obstet Gynecol 1998;11:391-400. -
UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation.
Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH.
Lancet 1998;352:343-6. -
Detection of sex chromosome abnormalities by nuchal translucency screening at 10-14 weeks.
Sebire NJ, Snijders RJ, Brown R, Southall T, Nicolaides KH.
Prenat Diagn 1998;18:581-4. -
Personal coping resources, responsibility, anxiety and depression after early pregnancy loss.
Nikcevic AV, Kuczmierczyk AR, Nicolaides KH.
J Psychosom Obstet Gynaecol 1998;19:145-54. -
Psychological outcomes following missed abortions and provision of follow-up care.
Nikcevic AV, Tunkel SA, Nicolaides KH.
Ultrasound Obstet Gynecol 1998;11:123-8. -
Correct estimation of parameters for ultrasound nuchal translucency screening.
Nicolaides KH, Snijders RJ, Cuckle HS.
Prenat Diagn 1998;18:519-23. -
Screening for chromosomal abnormalities at 10-14 weeks: the role of ductus venosus blood flow.
Matias A, Gomes C, Flack N, Montenegro N, Nicolaides KH.
Ultrasound Obstet Gynecol 1998;12:380-4. -
Biochemical analyses of mesenchymal fluid in early pregnancy.
Jauniaux E, Gulbis B, Hyett J, Nicolaides KH.
Am J Obstet Gynecol 1998;178:765-9. -
The umbilical artery pulsatility index in the first trimester: is there an association with increased nuchal translucency or chromosomal abnormality?
Brown R, Di Luzio L, Gomes C, Nicolaides KH.
Ultrasound Obstet Gynecol 1998;12:244-7. -
Outcome of chromosomally normal livebirths with increased fetal nuchal translucency at 10-14 weeks' gestation.
Brady AF, Pandya PP, Yuksel B, Greenough A, Patton MA, Nicolaides KH.
J Med Genet 1998;35:222-4. -
Perinatal lung function and invasive antenatal procedures.
Yuksel B, Greenough A, Naik S, Cheeseman P, Nicolaides KH.
Thorax 199752:181-4. -
Cardiac expression of sarcoplasmic reticulum calcium ATPase in fetuses with trisomy 21 and trisomy 18 presenting with nuchal translucency.
von Kaisenberg CS, Huggon I, Hyett JA, Farzaneh F, Nicolaides KH.
Fetal Diagn Ther 1997:12:270-3. -
First trimester urine free beta hCG, beta core, and total oestriol in pregnancies affected by Down's syndrome: implications for first-trimester screening with nuchal translucency and serum free beta hCG.
Spencer K, Noble P, Snijders RJ, Nicolaides KH.
Prenat Diagn 1997;17:525-38.